BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35908535)

  • 1. Prevalence and Clinical Characteristics of Paraproteinemia Associated with Chronic Myeloid Leukemia.
    Berger T; Shacham Abulafia A; Shimony S; Pasvolsky O; Vaxman I; Miron Y; Feldman S; Leader A; Raanani P
    Acta Haematol; 2022; 145(6):619-626. PubMed ID: 35908535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
    El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
    Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does my patient with a serum monoclonal spike have multiple myeloma?
    Bianchi G; Ghobrial IM
    Hematol Oncol Clin North Am; 2012 Apr; 26(2):383-93, ix. PubMed ID: 22463833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA
    Eur J Haematol Suppl; 1989; 51():70-5. PubMed ID: 2516809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal gammopathy of unknown significance and malignant paraproteinemia in Hong Kong.
    Lolin YI; Chow J; Wickham NW
    Am J Clin Pathol; 1996 Oct; 106(4):449-56. PubMed ID: 8853031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of monoclonal gammopathy in Morocco - A hospital-based study.
    Ouzzif Z; Doghmi K; Messaoudi N; Bouhsain S; El Machtani S; Biaz A; Rachid A; Dami A; Bezza A; El Maataoui A
    Cancer Rep (Hoboken); 2023 May; 6(5):e1814. PubMed ID: 36999311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: IgG multiple myeloma and chronic myeloid leukemia in a single patient.
    Swaminathan N; Gupta S; Dourado C
    F1000Res; 2020; 9():488. PubMed ID: 33042520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S
    Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma.
    Goyal G; Rajkumar SV; Lacy MQ; Gertz MA; Buadi FK; Dispenzieri A; Hwa YL; Fonder AL; Hobbs MA; Hayman SR; Zeldenrust SR; Lust JA; Russell SJ; Leung N; Kapoor P; Go RS; Gonsalves WI; Kourelis TV; Warsame R; Kyle RA; Kumar SK
    Leukemia; 2019 May; 33(5):1273-1277. PubMed ID: 30787429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study.
    Golombick T; Diamond TH; Manoharan A; Ramakrishna R
    Integr Cancer Ther; 2016 Jun; 15(2):183-9. PubMed ID: 27154182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
    Kyle RA; Rajkumar SV
    Oncology (Williston Park); 2011 Jun; 25(7):578-86. PubMed ID: 21888255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Willrich MAV; Murray DL; Kyle RA
    Clin Biochem; 2018 Jan; 51():38-47. PubMed ID: 28479151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal gammopathy of uncertain significance.
    Alejo E; Puertas B; Mateos MV
    Med Clin (Barc); 2023 Sep; 161(5):217-224. PubMed ID: 37330390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal gammopathy of undetermined significance and evolution to myeloma: Experience in 153 patients].
    López Gómez JM; Sacristán Enciso B; Fernández-Cavada Pollo MJ; Bueno García V; Gómez Vera S
    Semergen; 2021 Oct; 47(7):441-447. PubMed ID: 34479794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal gammopathies of unknown significance and smoldering myeloma: Assessment and management of the elderly patients.
    González-Calle V; Mateos MV
    Eur J Intern Med; 2018 Dec; 58():57-63. PubMed ID: 29907380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
    Murray D; Kumar SK; Kyle RA; Dispenzieri A; Dasari S; Larson DR; Vachon C; Cerhan JR; Rajkumar SV
    Blood Cancer J; 2019 Dec; 9(12):102. PubMed ID: 31836698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of monoclonal gammopathy of uncertain significance in chronic myeloid leukemia: A case report.
    Ouyang W; Zhao X; Lu S; Wang Z
    Medicine (Baltimore); 2018 Nov; 97(44):e13103. PubMed ID: 30383696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
    J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of chronic myelogenous leukemia and multiple myeloma. Case report and review of the literature.
    Tanaka M; Kimura R; Matsutani A; Zaitsu K; Oka Y; Oizumi K
    Acta Haematol; 1998; 99(4):221-3. PubMed ID: 9644301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.